Unlocking the potential of biosimilars with Cromos Pharma
Unlocking the potential of biosimilars with Cromos Pharma Biosimilars have long been heralded as a way of unlocking the potential of biologics by reducing costs to healthcare systems and increasing access to life-changing treatments. The development of biosimilar markets has differed across the world with European and APAC regions leading the way in terms of uptake, while the US has been slower to
Cromos Pharma delivering clinical trial success in breast cancer studies
Cromos Pharma delivering clinical trial success in breast cancer studies As Breast Cancer Awareness Month 2021 comes to an end, Cromos Pharma is pleased to share its experience with successful breast cancer clinical studies. This article outlines Cromos Pharma’s strong track record working with top international pharma and biotech sponsors on breast cancer studies. Over 16 years delivering clinical trial success in breast cancer studies
Connect with Cromos Pharma at 40th JP Morgan Healthcare Conference
Connect with Cromos Pharma at 40th JP Morgan Healthcare Conference Meet with Cromos Pharma during the 40th JP Morgan Healthcare Conference, January 2022. Cromos Pharma is delighted to be participating again at this prestigious invite-only event. Meet with Cromos Pharma during the 40th JP Morgan Healthcare Conference, January 2022. Cromos Pharma is delighted to be participating again at this prestigious invite-only event. LET OUR EXPERIENCE BENEFIT YOUR

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us